Literature DB >> 32138395

Immunohistochemical and immunoelectron microscopical localization of procollagen III peptide in papillary carcinoma of thyroid.

Ryohei Katoh1, Yoji Iida1, Koichi Suzuki1, Akira Kawaoi1, Akira Muramatsu2.   

Abstract

The immunohistochemical localization of procollagen III peptide, a precursor of type III collagen, was examined in 38 papillary carcinomas and 25 follicular neoplasms using an immu-noperoxidase technique. Although localization of procollagen ill peptide was not demonstrated in normal follicular cells, distinct cytoplasmic immunostaining of neoplastic cells was frequently found in the tissues examined, as were stromal fibroblasts. Such cytoplasmic immunostaining was observed in 92.1 % of 38 papillary carcinomas and in 36.0% of 25 follicular neoplasms. Cytoplasmic immunoreactivity in papillary carcinomas was more intense at the peripheral zone of the tumor and correlated with the degree of invasiveness. The controls, in which the primary antibody was preabsorbed with procollagen ill peptide or replaced with normal rabbit serum, showed only faint background staining in all specimens. Immunoelectron microscopical examination revealed that electron-dense deposits, indicating procollagen III peptide, were located in the perinuclear space, Golgi apparatus, and rough endoplasmic reticulum of papillary carcinoma cells. These results suggest that neoplastic cells, especially papillary carcinoma cells, could play an important role in type III collagen production, possibly in connection with the creation of an environment that is conducive to their progression.

Entities:  

Keywords:  Endocrine Pathology Volume; Follicular Adenoma; Follicular Carcinoma; Papillary Carcinoma; Papillary Thyroid Carcinoma

Year:  1992        PMID: 32138395     DOI: 10.1007/BF02921353

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  9 in total

1.  Type I and type III procollagen peptides during hepatic fibrogenesis. An immunohistochemical and ELISA serum study in the CCl4 rat model.

Authors:  B H Davis; J A Madri
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

2.  Immunolocalization of type III collagen and procollagen in cirrhotic human liver using monoclonal antibodies.

Authors:  K Sakakibara; A Ooshima; S Igarashi; J Sakakibara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  An immunohistochemical study of laminin, type-IV collagen and type-III pN-collagen with relation to reticular fibres in Hodgkin's disease.

Authors:  T Karttunen; M Alavaikko; M Apaja-Sarkkinen; H Autio-Harmainen
Journal:  Int J Cancer       Date:  1988-01-15       Impact factor: 7.396

4.  The route of secretion of procollagen. The influence of alphaalpha'-bipyridyl, colchicine and antimycin A on the secretory process in embryonic-chick tendon and cartilage cells.

Authors:  R Harwood; M E Grant; D S Jackson
Journal:  Biochem J       Date:  1976-04-15       Impact factor: 3.857

5.  Serum basement membrane and type III procollagen-related antigens in primary biliary cirrhosis.

Authors:  O Niemelä; L Risteli; E A Sotaniemi; F Stenbäck; J Risteli
Journal:  J Hepatol       Date:  1988-06       Impact factor: 25.083

6.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

7.  Production of collagen fibrils in adrenocortical adenoma with Cushing's syndrome.

Authors:  K Matsuo; H Tsuchiyama
Journal:  Acta Pathol Jpn       Date:  1987-04

8.  Localization of type III procollagen aminopeptide antigenicity in hepatocytes from cirrhotic human liver.

Authors:  K Sakakibara; S Igarashi; T Hatahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

9.  Further characterization of embryonic tendon fibroblasts and the use of immunoferritin techniques to study collagen biosynthesis.

Authors:  B R Olsen; R A Berg; Y Kishida; D J Prockop
Journal:  J Cell Biol       Date:  1975-02       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.